Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study.

Ascha MS, Funk K, Sloan AE, Kruchko C, Barnholtz-Sloan JS.

Clin Exp Metastasis. 2019 Nov 8. doi: 10.1007/s10585-019-10005-2. [Epub ahead of print]

PMID:
31705229
2.

Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015.

Wright CH, Wright J, Cioffi G, Hdeib A, Kasliwal MK, Kruchko C, Barnholtz-Sloan JS, Sloan AE.

J Neurosurg Spine. 2019 Nov 1:1-10. doi: 10.3171/2019.7.SPINE19566. [Epub ahead of print]

PMID:
31675723
3.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2019 Nov 1;21(Supplement_5):v1-v100. doi: 10.1093/neuonc/noz150.

PMID:
31675094
4.

Brain tumor disparities: From biology to social determinants - The 2019 Brain Tumor Epidemiology Consortium meeting report.

Johnson KJ, Bauchet L, Hainfellner JA, Kruchko C, Scheurer ME, Wiemels J, Schwartzbaum J.

Clin Neuropathol. 2019 Nov/Dec;38(6):297-305. doi: 10.5414/NP301234.

PMID:
31661066
5.

Pilocytic astrocytoma: Where do they belong in cancer reporting?

Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2019 Oct 22. pii: noz202. doi: 10.1093/neuonc/noz202. [Epub ahead of print] No abstract available.

PMID:
31637436
6.

Cancer collection efforts in the United States provide clinically relevant data on all primary brain and other CNS tumors.

Kruchko C, Gittleman H, Ruhl J, Hofferkamp J, Ward EM, Ostrom QT, Sherman RL, Jones SF, Barnholtz-Sloan JS, Wilson RJ.

Neurooncol Pract. 2019 Sep;6(5):330-339. doi: 10.1093/nop/npz029. Epub 2019 Jul 2. Review.

PMID:
31555447
7.

Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.

Truitt G, Gittleman H, Leece R, Ostrom QT, Kruchko C, Armstrong TS, Gilbert MR, Barnholtz-Sloan JS.

J Neurooncol. 2019 Aug;144(1):53-63. doi: 10.1007/s11060-019-03215-x. Epub 2019 Jun 17.

PMID:
31209773
8.

Glioma incidence and survival variations by county-level socioeconomic measures.

Cote DJ, Ostrom QT, Gittleman H, Duncan KR, CreveCoeur TS, Kruchko C, Smith TR, Stampfer MJ, Barnholtz-Sloan JS.

Cancer. 2019 Oct 1;125(19):3390-3400. doi: 10.1002/cncr.32328. Epub 2019 Jun 17.

PMID:
31206646
9.

Survival in Patients with High-Grade Spinal Meningioma: An Analysis of the National Cancer Database.

Wright JM, Wright CH, Cioffi G, Raghavan A, Hdeib A, Kasliwal MK, Kruchko C, Barnholtz-Sloan JS, Sloan AE.

World Neurosurg. 2019 Sep;129:e749-e753. doi: 10.1016/j.wneu.2019.06.015. Epub 2019 Jun 14.

PMID:
31203074
10.

Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.

Ascha MS, Ostrom QT, Wright J, Kumthekar P, Bordeaux JS, Sloan AE, Schumacher FR, Kruchko C, Barnholtz-Sloan JS.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):917-925. doi: 10.1158/1055-9965.EPI-18-1116.

PMID:
31053636
11.

Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.

Gittleman H, Cioffi G, Vecchione-Koval T, Ostrom QT, Kruchko C, Osorio DS, Finlay JL, Barnholtz-Sloan JS.

J Neurooncol. 2019 Jun;143(2):251-260. doi: 10.1007/s11060-019-03173-4. Epub 2019 Apr 25.

PMID:
31025275
12.

Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database.

Wright JM, Hodges TR, Wright CH, Gittleman H, Zhou X, Duncan K, Kruchko C, Sloan A, Barnholtz-Sloan JS.

J Neurooncol. 2019 Jun;143(2):349-357. doi: 10.1007/s11060-019-03170-7. Epub 2019 Apr 13.

PMID:
30989622
13.

Global collection of "benign" CNS tumors.

Kruchko C.

Neuro Oncol. 2019 Apr 8. pii: noz064. doi: 10.1093/neuonc/noz064. [Epub ahead of print] No abstract available.

PMID:
30957853
14.

Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.

Dandachi D, Ostrom QT, Chong I, Serpa JA, Giordano TP, Kruchko C, Barnholtz-Sloan JS, Fowler N, Colen RR, Morón FE.

Cancer Causes Control. 2019 May;30(5):477-488. doi: 10.1007/s10552-019-01144-8. Epub 2019 Mar 19.

PMID:
30888569
15.

The epidemiology of central and extraventricular neurocytoma in the United States between 2006 and 2014.

Tish S, Habboub G, Jones J, Ostrom QT, Kruchko C, Barnholtz-Sloan JS, Recinos PF, Kshettry VR.

J Neurooncol. 2019 May;143(1):123-127. doi: 10.1007/s11060-019-03144-9. Epub 2019 Mar 11.

PMID:
30859483
16.

Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013.

Walker EV, Davis FG; CBTR founding affiliates.

Neuro Oncol. 2019 Feb 19;21(3):360-369. doi: 10.1093/neuonc/noy195.

17.

Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival.

Ostrom QT, Gittleman H, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2019 Mar;142(1):27-38. doi: 10.1007/s11060-018-03073-z. Epub 2018 Dec 12.

PMID:
30543034
18.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.

Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86. doi: 10.1093/neuonc/noy131. Review. No abstract available.

19.

Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005-2015, using the Central Brain Tumor Registry of the United States.

Achey RL, Gittleman H, Schroer J, Khanna V, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2019 Feb 19;21(3):380-391. doi: 10.1093/neuonc/noy162.

PMID:
30295804
20.

A comparison of relative survival and cause-specific survival methods to measure net survival in cancer populations.

Makkar N, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

Cancer Med. 2018 Sep;7(9):4773-4780. doi: 10.1002/cam4.1706. Epub 2018 Aug 1.

21.

Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.

Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS.

JAMA Oncol. 2018 Sep 1;4(9):1254-1262. doi: 10.1001/jamaoncol.2018.1789.

22.

Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014.

Gittleman H, Boscia A, Ostrom QT, Truitt G, Fritz Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Nov 9;20(suppl_7):vii6-vii16. doi: 10.1093/neuonc/noy090.

23.

The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone.

Kruchko C, Ostrom QT, Gittleman H, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Feb 19;20(3):295-298. doi: 10.1093/neuonc/noy006. No abstract available.

24.

CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.

Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88. doi: 10.1093/neuonc/nox158. No abstract available.

25.

The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.

Mendez JS, Ostrom QT, Gittleman H, Kruchko C, DeAngelis LM, Barnholtz-Sloan JS, Grommes C.

Neuro Oncol. 2018 Apr 9;20(5):687-694. doi: 10.1093/neuonc/nox187.

26.

Brain tumor epidemiology in the era of precision medicine: The 2017 Brain Tumor Epidemiology Consortium meeting report.

Johnson KJ, Schwartzbaum J, Kruchko C, Scheurer ME, Lau CC, Woehrer A, Hainfellner JA, Wiemels J.

Clin Neuropathol. 2017 Nov/Dec;36(6):255-263. doi: 10.5414/NP301066.

27.

Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.

Khanna V, Achey RL, Ostrom QT, Block-Beach H, Kruchko C, Barnholtz-Sloan JS, de Blank PM.

J Neurooncol. 2017 Dec;135(3):433-441. doi: 10.1007/s11060-017-2594-6. Epub 2017 Aug 21.

PMID:
28828582
28.

Do race and age vary in non-malignant central nervous system tumor incidences in the United States?

Gittleman H, Cote DJ, Ostrom QT, Kruchko C, Smith TR, Claus EB, Barnholtz-Sloan JS.

J Neurooncol. 2017 Sep;134(2):269-277. doi: 10.1007/s11060-017-2543-4. Epub 2017 Jun 30.

PMID:
28667594
29.

Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.

Kromer C, Xu J, Ostrom QT, Gittleman H, Kruchko C, Sawaya R, Barnholtz-Sloan JS.

J Neurooncol. 2017 Aug;134(1):55-64. doi: 10.1007/s11060-017-2516-7. Epub 2017 May 31.

PMID:
28567587
30.

Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007.

Leece R, Xu J, Ostrom QT, Chen Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2017 Oct 19;19(11):1553-1564. doi: 10.1093/neuonc/nox091.

31.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.

Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2016 Oct 1;18(suppl_5):v1-v75. doi: 10.1093/neuonc/now207. No abstract available.

PMID:
28475809
32.

Is mortality due to primary malignant brain and other central nervous system tumors decreasing?

Gittleman H, Kromer C, Ostrom QT, Blanda R, Russell J, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2017 Jun;133(2):265-275. doi: 10.1007/s11060-017-2449-1. Epub 2017 May 3.

PMID:
28470430
33.

Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.

Achey RL, Khanna V, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2017 May;133(1):17-25. doi: 10.1007/s11060-017-2414-z. Epub 2017 Apr 10.

PMID:
28397028
34.

Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.

Zhang AS, Ostrom QT, Kruchko C, Rogers L, Peereboom DM, Barnholtz-Sloan JS.

Neuro Oncol. 2017 May 1;19(5):726-735. doi: 10.1093/neuonc/now252.

35.

Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).

Ostrom QT, Gittleman H, Kruchko C, Louis DN, Brat DJ, Gilbert MR, Petkov VI, Barnholtz-Sloan JS.

J Neurooncol. 2016 Oct;130(1):31-42. Epub 2016 Jul 14.

36.

Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based Registry.

Chien LN, Gittleman H, Ostrom QT, Hung KS, Sloan AE, Hsieh YC, Kruchko C, Rogers LR, Wang YF, Chiou HY, Barnholtz-Sloan JS.

Front Public Health. 2016 Jul 21;4:151. doi: 10.3389/fpubh.2016.00151. eCollection 2016.

37.

Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995-2012.

Farah P, Blanda R, Kromer C, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2016 Jul;128(3):419-29. doi: 10.1007/s11060-016-2127-8. Epub 2016 Apr 19.

PMID:
27095247
38.

Are Benign and Borderline Brain Tumors Underreported?

Li XR, Kruchko C, Wu XC, Hsieh MC, Andrews PA, Huang B, Qiao B, Wohler B.

J Registry Manag. 2016 Winter;43(4):187-94.

PMID:
29595921
39.

American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Ostrom QT, Gittleman H, de Blank PM, Finlay JL, Gurney JG, McKean-Cowdin R, Stearns DS, Wolff JE, Liu M, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2016 Jan;18 Suppl 1:i1-i50. doi: 10.1093/neuonc/nov297. No abstract available.

40.

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62. doi: 10.1093/neuonc/nov189. Epub 2015 Oct 27. No abstract available.

41.

Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010.

Rouse C, Gittleman H, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2016 Jan;18(1):70-7. doi: 10.1093/neuonc/nov249. Epub 2015 Oct 12.

42.

Incidence of vestibular schwannomas in the United States.

Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2015 Sep;124(2):223-8. doi: 10.1007/s11060-015-1827-9. Epub 2015 May 30.

PMID:
26024654
43.

Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.

Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS.

Neuro Oncol. 2015 Aug;17(8):1166-73. doi: 10.1093/neuonc/nov069. Epub 2015 May 24.

44.

Descriptive Epidemiology of Spinal Meningiomas in the United States.

Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Benzel EC, Barnholtz-Sloan JS.

Spine (Phila Pa 1976). 2015 Aug 1;40(15):E886-9. doi: 10.1097/BRS.0000000000000974.

PMID:
25996535
45.

Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011.

Lym RL, Ostrom QT, Kruchko C, Couce M, Brat DJ, Louis DN, Barnholtz-Sloan JS.

J Neurooncol. 2015 May;123(1):43-51. doi: 10.1007/s11060-015-1775-4. Epub 2015 Apr 12.

46.

Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009.

de Blank PM, Ostrom QT, Rouse C, Wolinsky Y, Kruchko C, Salcido J, Barnholtz-Sloan JS.

Cancer Med. 2015 Apr;4(4):608-19. doi: 10.1002/cam4.410. Epub 2015 Jan 27.

47.

Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS.

Neuro Oncol. 2015 Jan;16 Suppl 10:x1-x36. doi: 10.1093/neuonc/nou327.

48.

Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014.

Woehrer A, Lau CC, Prayer D, Bauchet L, Rosenfeld M, Capper D, Fisher PG, Kool M, Müller M, Kros JM, Kruchko C, Wiemels J, Wrensch M, Danysh HE, Zouaoui S, Heck JE, Johnson KJ, Qi X, O'Neill BP, Afzal S, Scheurer ME, Bainbridge MN, Nousome D, Bahassi el M, Hainfellner JA, Barnholtz-Sloan JS; Brain Tumor Epidemiology Consortium.

Clin Neuropathol. 2015 Jan-Feb;34(1):40-6.

49.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J.

Neuro Oncol. 2014 Oct;16 Suppl 4:iv1-63. doi: 10.1093/neuonc/nou223. No abstract available.

50.

Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010.

Gittleman HR, Ostrom QT, Rouse CD, Dowling JA, de Blank PM, Kruchko CA, Elder JB, Rosenfeld SS, Selman WR, Sloan AE, Barnholtz-Sloan JS.

Cancer. 2015 Jan 1;121(1):102-12. doi: 10.1002/cncr.29015. Epub 2014 Aug 25.

Supplemental Content

Loading ...
Support Center